Anti-Vascular Endothelial Growth Factor Therapy in Breast Cancer

Neo-angiogenesis is a critical process for tumor growth and invasion and has become a promising target in cancer therapy. This manuscript reviews three currently relevant anti-angiogenic agents targeting the vascular endothelial growth factor system: bevacizumab, ramucirumab and sorafenib. The effic...

Descripción completa

Detalles Bibliográficos
Autores principales: Kristensen, Tina Bøgelund, Knutsson, Malin L. T., Wehland, Markus, Laursen, Britt Elmedal, Grimm, Daniela, Warnke, Elisabeth, Magnusson, Nils E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2014
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4284752/
https://www.ncbi.nlm.nih.gov/pubmed/25514409
http://dx.doi.org/10.3390/ijms151223024

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4284752/
https://www.ncbi.nlm.nih.gov/pubmed/25514409
http://dx.doi.org/10.3390/ijms151223024

Ejemplares similares